Armistice Capital’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,256,000
| Closed | -$10.8M | – | 144 |
|
|
2020
Q4 | $10.8M | Buy |
2,256,000
+408,000
| +22% | +$1.96M | 0.37% | 66 |
|
|
2020
Q3 | $10.8M | Buy |
1,848,000
+248,000
| +16% | +$1.45M | 0.39% | 60 |
|
|
2020
Q2 | $10.8M | Buy |
+1,600,000
| New | +$10.8M | 0.47% | 58 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 89 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 84 |
|
|
2019
Q2 | – | Sell |
-2,100,000
| Closed | -$52.1M | – | 81 |
|
|
2019
Q1 | $52.1M | Sell |
2,100,000
-2,936,000
| -58% | -$72.9M | 2.85% | 5 |
|
|
2018
Q4 | $90.4M | Buy |
5,036,000
+3,400,000
| +208% | +$61.1M | 6.86% | 1 |
|
|
2018
Q3 | $48M | Buy |
1,636,000
+1,012,000
| +162% | +$29.7M | 2.88% | 3 |
|
|
2018
Q2 | $28.4M | Buy |
624,000
+156,000
| +33% | +$7.09M | 1.85% | 16 |
|
|
2018
Q1 | $24.7M | Buy |
+468,000
| New | +$24.7M | 1.89% | 20 |
|